Recombinant Mouse TNFRSF19 Protein
Beta LifeScience
SKU/CAT #: BLK-01017P-100UG

Mouse TNFRSF19 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse TNFRSF19 Protein
Beta LifeScience
SKU/CAT #: BLK-01017P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse TNFRSF19 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Glu30-Leu170. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9JLL3 |
Target Symbol | TNFRSF19 |
Species | Mouse |
Expression System | HEK293 |
Tag | C-hFc |
Expression Range | Glu30-Leu170 |
Mol. Weight | The protein has a predicted MW of 42.34 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | A novel susceptibility gene TNFRSF19, which encodes an orphan member of the TNF receptor superfamily known to be associated with nasopharyngeal carcinoma (NPC) and lung cancer risk. TNFRSF19, a susceptibility gene for nasopharyngeal carcinoma and other cancers, functions as a potent inhibitor of the TGFβ signaling pathway. |